Award
Delivery Order #SPE2DR26FN4H4
AmerisourceBergen Drug Corp Delivery Order for Novolog Insulin Vials
Buyer
Defense Logistics Agency
Award Amount
$3,252.68
Ceiling
$3,252.68
Awarded
February 24, 2026
Period of Performance
Feb 24, 2026 – Feb 25, 2026
Identifier
SPE2DR26FN4H4
NAICS
424210
This award represents a delivery order contract issued under an existing Indefinite Delivery Vehicle (IDV) held by AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company. The order procures Novolog insulin in 100 unit/ml 10 ml vials, critical for managing diabetes and supporting public health initiatives. The delivery order is a short-term, specific procurement facilitating timely supply to meet immediate healthcare needs at the Conshohocken, PA location. Given it is issued under a long-term multi-year IDV contract focused on pharmaceutical distribution, this delivery order ensures the continuation of essential medication availability within federal healthcare systems. The order was not competitively bid, consistent with the IDV’s structure, allowing streamlined procurement. The contract period covers one day, reflecting prompt fulfillment requirements. This transaction complements AmerisourceBergen’s ongoing role in delivering pharmaceutical products under the broader 2025-2036 IDV contract, maintaining critical medicine supply chains for government health programs.
Description
4570940980!NOVOLOG 100 UNIT/ML VIAL 10ML